Entry
Name
Envudeucitinib hydrochloride (USAN)
Formula
C22H24N6O3. HCl
Exact mass
462.2053
Mol weight
456.92
Structure
Mol file KCF file DB search
Remark
Efficacy
Anti-inflammatory, Tyrosine kinase 2 inhibitor
Comment
Treatment of psoriasis and other immune-mediated inflammatory diseases
Target
Pathway
hsa04620 Toll-like receptor signaling pathway
hsa04621 NOD-like receptor signaling pathway
hsa04658 Th1 and Th2 cell differentiation
Brite
Target-based classification of drugs [BR:br08310 ]
Protein kinases
Non-receptor tyrosine kinases
JAK family
TYK2
D13124 Envudeucitinib hydrochloride (USAN)
BRITE hierarchy
Other DBs
LinkDB
All DBs
KCF data
Show ATOM 32
1 C8x C 13.1858 -14.9335
2 N5x N 13.1858 -16.3353
3 C8y C 14.3774 -17.0363
4 C8x C 15.5690 -16.3353
5 C8y C 15.5690 -14.9335
6 C8y C 14.3774 -14.2325
7 C5a C 14.3774 -12.8306
8 C1b C 13.1858 -12.1297
9 O5a O 15.4989 -12.1297
10 C1a C 11.9942 -12.8306
11 N1b N 14.3774 -18.4382
12 C5a C 13.1858 -19.0690
13 C1y C 11.9942 -18.4382
14 O5a O 13.1858 -20.4709
15 C1x C 11.2933 -17.1765
16 C1x C 10.5222 -18.4382
17 N1b N 16.8307 -14.1624
18 C8y C 18.0924 -14.8634
19 C8x C 18.0924 -16.3353
20 C8x C 19.2840 -16.9662
21 C8x C 20.5457 -16.2653
22 C8y C 20.5457 -14.8634
23 C8y C 19.2840 -14.1624
24 O2a O 19.2840 -12.8306
25 C8y C 21.7373 -14.1624
26 N5x N 22.1579 -12.8306
27 C8x C 23.5598 -12.8306
28 N4y N 23.9803 -14.1624
29 N5x N 22.8588 -14.9335
30 C1a C 25.3121 -14.5830
31 C1a C 20.4756 -12.1297
32 X Cl 25.1300 -19.9500
BOND 34
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 6 7 1
8 7 8 1
9 7 9 2
10 8 10 1
11 3 11 1
12 11 12 1
13 13 12 1
14 12 14 2
15 16 15 1
16 15 13 1
17 13 16 1
18 5 17 1
19 17 18 1
20 18 19 2
21 19 20 1
22 20 21 2
23 21 22 1
24 22 23 2
25 18 23 1
26 23 24 1
27 22 25 1
28 25 26 1
29 26 27 2
30 27 28 1
31 28 29 1
32 25 29 2
33 28 30 1
34 24 31 1